1The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [J]. N Engl J Med, 1993,329:683-689.
2UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes [J]. Lancet, 1998,352:837-853.
3Pedersen O, Gaede P. Intensified muhifactorial intervention and cardiovascular outcome in type 2 diabetes: the steno-2 study [J]. Metabolism, 2003,52: 19-23.
4Abraira C, Duckworth W, McCarren M, et al. Design of cooperative study of glycemic control and complications in diabetes mellitus type2 [J]. J Diabetes Compl, 2003,17:314-322.
5Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial [DB/OL]. http://www, clinical-trials, gov/ct/show/NCT000006207 order=1.
6Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study [J]. Diabetes Care, 1997,20: 537-544.
7The Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance [J]. N Engl J Med, 2001,344:1343-1350.
8The DPP Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J]. N Engl J Med, 2002,346: 393-403.
9Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention type 2 diabetes mellitus:STOP-NIDDM randomised trial [J].Lancet, 2002, 359:2072-2077.
10Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J]. Diabetes, 2002,51:2796-2803.
